Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress

Matteo Bauckneht, Fabio Pastorino, Patrizia Castellani, Vanessa Cossu, Anna Maria Orengo, Patrizia Piccioli, Laura Emionite, Selene Capitanio, Nikola Yosifov, Silvia Bruno, Edoardo Lazzarini, Mirco Ponzoni, Pietro Ameri, Anna Rubartelli, Silvia Ravera, Silvia Morbelli, Gianmario Sambuceti, Cecilia Marini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Oxidative stress and its interference on myocardial metabolism play a major role in Doxorubicin (DXR) cardiotoxic cascade. Methods: Mice models of neuroblastoma (NB) were treated with 5 mg DXR/kg, either free (Free-DXR) or encapsulated in untargeted (SL[DXR]) or in NB-targeting Stealth Liposomes (pep-SL[DXR] and TP-pep-SL[DXR]). Control mice received saline. FDG-PET was performed at baseline (PET1) and 7 days after therapy (PET2). At PET2 Troponin-I and NT-proBNP were assessed. Explanted hearts underwent biochemical, histological, and immunohistochemical analyses. Finally, FDG uptake and glucose consumption were simultaneously measured in cultured H9c2 in the presence/absence of Free-DXR (1 μM). Results: Free-DXR significantly enhanced the myocardial oxidative stress. Myocardial-SUV remained relatively stable in controls and mice treated with liposomal formulations, while it significantly increased at PET2 with respect to baseline in Free-DXR. At this timepoint, myocardial-SUV was directly correlated with both myocardial redox stress and hexose-6-phosphate-dehydrogenase (H6PD) enzymatic activity, which selectively sustain cellular anti-oxidant mechanisms. Intriguingly, in vitro, Free-DXR selectively increased FDG extraction fraction without altering the corresponding value for glucose. Conclusion: The direct correlation between cardiac FDG uptake and oxidative stress indexes supports the potential role of FDG-PET as an early biomarker of DXR oxidative damage.

Original languageEnglish
JournalJournal of Nuclear Cardiology
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Doxorubicin
Oxidative Stress
Neuroblastoma
Glucose
Troponin I
Oxidants
Liposomes
Oxidation-Reduction
Biomarkers

Keywords

  • cardiotoxicity
  • Doxorubicin
  • myocardial metabolism
  • oxidative stress, hexose-6-phosphate-dehydrogenase
  • Positron emission tomography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress. / Bauckneht, Matteo; Pastorino, Fabio; Castellani, Patrizia; Cossu, Vanessa; Orengo, Anna Maria; Piccioli, Patrizia; Emionite, Laura; Capitanio, Selene; Yosifov, Nikola; Bruno, Silvia; Lazzarini, Edoardo; Ponzoni, Mirco; Ameri, Pietro; Rubartelli, Anna; Ravera, Silvia; Morbelli, Silvia; Sambuceti, Gianmario; Marini, Cecilia.

In: Journal of Nuclear Cardiology, 01.01.2019.

Research output: Contribution to journalArticle

@article{90f076d7506247499556a6b8a6c8d97d,
title = "Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress",
abstract = "Background: Oxidative stress and its interference on myocardial metabolism play a major role in Doxorubicin (DXR) cardiotoxic cascade. Methods: Mice models of neuroblastoma (NB) were treated with 5 mg DXR/kg, either free (Free-DXR) or encapsulated in untargeted (SL[DXR]) or in NB-targeting Stealth Liposomes (pep-SL[DXR] and TP-pep-SL[DXR]). Control mice received saline. FDG-PET was performed at baseline (PET1) and 7 days after therapy (PET2). At PET2 Troponin-I and NT-proBNP were assessed. Explanted hearts underwent biochemical, histological, and immunohistochemical analyses. Finally, FDG uptake and glucose consumption were simultaneously measured in cultured H9c2 in the presence/absence of Free-DXR (1 μM). Results: Free-DXR significantly enhanced the myocardial oxidative stress. Myocardial-SUV remained relatively stable in controls and mice treated with liposomal formulations, while it significantly increased at PET2 with respect to baseline in Free-DXR. At this timepoint, myocardial-SUV was directly correlated with both myocardial redox stress and hexose-6-phosphate-dehydrogenase (H6PD) enzymatic activity, which selectively sustain cellular anti-oxidant mechanisms. Intriguingly, in vitro, Free-DXR selectively increased FDG extraction fraction without altering the corresponding value for glucose. Conclusion: The direct correlation between cardiac FDG uptake and oxidative stress indexes supports the potential role of FDG-PET as an early biomarker of DXR oxidative damage.",
keywords = "cardiotoxicity, Doxorubicin, myocardial metabolism, oxidative stress, hexose-6-phosphate-dehydrogenase, Positron emission tomography",
author = "Matteo Bauckneht and Fabio Pastorino and Patrizia Castellani and Vanessa Cossu and Orengo, {Anna Maria} and Patrizia Piccioli and Laura Emionite and Selene Capitanio and Nikola Yosifov and Silvia Bruno and Edoardo Lazzarini and Mirco Ponzoni and Pietro Ameri and Anna Rubartelli and Silvia Ravera and Silvia Morbelli and Gianmario Sambuceti and Cecilia Marini",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12350-019-01618-x",
language = "English",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",

}

TY - JOUR

T1 - Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress

AU - Bauckneht, Matteo

AU - Pastorino, Fabio

AU - Castellani, Patrizia

AU - Cossu, Vanessa

AU - Orengo, Anna Maria

AU - Piccioli, Patrizia

AU - Emionite, Laura

AU - Capitanio, Selene

AU - Yosifov, Nikola

AU - Bruno, Silvia

AU - Lazzarini, Edoardo

AU - Ponzoni, Mirco

AU - Ameri, Pietro

AU - Rubartelli, Anna

AU - Ravera, Silvia

AU - Morbelli, Silvia

AU - Sambuceti, Gianmario

AU - Marini, Cecilia

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Oxidative stress and its interference on myocardial metabolism play a major role in Doxorubicin (DXR) cardiotoxic cascade. Methods: Mice models of neuroblastoma (NB) were treated with 5 mg DXR/kg, either free (Free-DXR) or encapsulated in untargeted (SL[DXR]) or in NB-targeting Stealth Liposomes (pep-SL[DXR] and TP-pep-SL[DXR]). Control mice received saline. FDG-PET was performed at baseline (PET1) and 7 days after therapy (PET2). At PET2 Troponin-I and NT-proBNP were assessed. Explanted hearts underwent biochemical, histological, and immunohistochemical analyses. Finally, FDG uptake and glucose consumption were simultaneously measured in cultured H9c2 in the presence/absence of Free-DXR (1 μM). Results: Free-DXR significantly enhanced the myocardial oxidative stress. Myocardial-SUV remained relatively stable in controls and mice treated with liposomal formulations, while it significantly increased at PET2 with respect to baseline in Free-DXR. At this timepoint, myocardial-SUV was directly correlated with both myocardial redox stress and hexose-6-phosphate-dehydrogenase (H6PD) enzymatic activity, which selectively sustain cellular anti-oxidant mechanisms. Intriguingly, in vitro, Free-DXR selectively increased FDG extraction fraction without altering the corresponding value for glucose. Conclusion: The direct correlation between cardiac FDG uptake and oxidative stress indexes supports the potential role of FDG-PET as an early biomarker of DXR oxidative damage.

AB - Background: Oxidative stress and its interference on myocardial metabolism play a major role in Doxorubicin (DXR) cardiotoxic cascade. Methods: Mice models of neuroblastoma (NB) were treated with 5 mg DXR/kg, either free (Free-DXR) or encapsulated in untargeted (SL[DXR]) or in NB-targeting Stealth Liposomes (pep-SL[DXR] and TP-pep-SL[DXR]). Control mice received saline. FDG-PET was performed at baseline (PET1) and 7 days after therapy (PET2). At PET2 Troponin-I and NT-proBNP were assessed. Explanted hearts underwent biochemical, histological, and immunohistochemical analyses. Finally, FDG uptake and glucose consumption were simultaneously measured in cultured H9c2 in the presence/absence of Free-DXR (1 μM). Results: Free-DXR significantly enhanced the myocardial oxidative stress. Myocardial-SUV remained relatively stable in controls and mice treated with liposomal formulations, while it significantly increased at PET2 with respect to baseline in Free-DXR. At this timepoint, myocardial-SUV was directly correlated with both myocardial redox stress and hexose-6-phosphate-dehydrogenase (H6PD) enzymatic activity, which selectively sustain cellular anti-oxidant mechanisms. Intriguingly, in vitro, Free-DXR selectively increased FDG extraction fraction without altering the corresponding value for glucose. Conclusion: The direct correlation between cardiac FDG uptake and oxidative stress indexes supports the potential role of FDG-PET as an early biomarker of DXR oxidative damage.

KW - cardiotoxicity

KW - Doxorubicin

KW - myocardial metabolism

KW - oxidative stress, hexose-6-phosphate-dehydrogenase

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=85061338972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061338972&partnerID=8YFLogxK

U2 - 10.1007/s12350-019-01618-x

DO - 10.1007/s12350-019-01618-x

M3 - Article

AN - SCOPUS:85061338972

JO - Journal of Nuclear Cardiology

JF - Journal of Nuclear Cardiology

SN - 1071-3581

ER -